Company
Vaxcyte
Vaccine Innovation. Beyond Convention.
Also known as Vaxcyte, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Carlos, CA, United States
- Founded
- 2013
- Legal name
- Vaxcyte, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Vaxcyte is a clinical-stage vaccine innovation company based in San Carlos, California with the unique ability to rapidly engineer, optimize and manufacture superior, high-fidelity vaccines at scale.
Funding snapshot
- Total raised
- $206MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $110M2020-03-20
Funding rounds
- Round, 2020
- $110M2020-03-20, SEC form D sold, 23 investors
- Round, 2018
- $43.2M2018-05-29, SEC form D sold, 12 investors
- Round, 2017
- $40.1M2017-03-03, SEC form D sold, 9 investors
- Round, 2015
- $12.6M2015-07-10, SEC form D sold, 7 investors
Products
- Other
- VAX-24
- Other
- VAX-31
Loading relationship preview